STOCK TITAN

Genpact CEO sells 10,000 shares at $36.79

Genpact LTD (G) reports that President and CEO Balkrishan Kalra sold 10,000 Common Shares on September 14, 2026 in a sale in open market or private transaction at a weighted average price of $36.79, with individual sale prices ranging from $36.790 to $36.795.

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Genpact LTD (G) reports that President and CEO Balkrishan Kalra sold 10,000 Common Shares on September 14, 2026 in a sale in open market or private transaction at a weighted average price of $36.79, with individual sale prices ranging from $36.790 to $36.795. Following this transaction, he directly holds 501,114 Common Shares, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Kalra Balkrishan
Role President and CEO
Sold 10,000 shs ($368K)
Type Security Shares Price Value
Sale Common Shares F1 10,000 $36.79 $368K
Holdings After Transaction: Common Shares — 501,114 shares (Direct)
Footnotes (1)
  1. F1. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.790 to $36.795. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares sold 10,000 shares Common Shares sold by President and CEO on September 14, 2026
Weighted average sale price $36.79 per share Weighted average price for the 10,000-share sale on September 14, 2026
Sale price range $36.790–$36.795 per share Range of actual sale prices disclosed in the footnote
Shares held after transaction 501,114 shares Common Shares directly owned by the CEO after the sale
weighted average price financial
"The price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
sale in open market or private transaction financial
"Transaction described as a sale in open market or private transaction"
SEC staff regulatory
"or the SEC staff, upon request, information regarding the number"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genpact (G) disclose for Balkrishan Kalra?

Genpact disclosed that President and CEO Balkrishan Kalra sold 10,000 Common Shares on September 14, 2026 in a sale classified as an open market or private transaction.

At what price did the CEO’s 10,000 Genpact (G) shares sell?

The 10,000 Common Shares were sold at a weighted average price of $36.79 per share. A footnote states that the actual sale prices ranged from $36.790 to $36.795 per share.

How many Genpact (G) shares does the CEO own after this sale?

After the September 14, 2026 transaction, President and CEO Balkrishan Kalra directly holds 501,114 Common Shares of Genpact LTD.

Was the CEO’s Genpact (G) share sale under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 plan is reported for the September 14, 2026 sale of 10,000 Common Shares.

What type of security did the CEO sell in Genpact (G)?

The transaction involved Common Shares of Genpact LTD. The filing reports a non-derivative transaction, meaning it did not involve options or other derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kalra Balkrishan

(Last)(First)(Middle)
C/O GENPACT LLC
521 FIFTH AVENUE, 14TH FLOOR

(Street)
NEW YORK NEW YORK 10175

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares09/14/2026S10,000D$36.79(1)501,114D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.790 to $36.795. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Remarks:
/s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading